Neo-Angin Benzydamin (Benzydamine Hydrochloride)

Benzydamine hydrochloride, the active ingredient in Neo-Angin Benzydamin, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oromucosal preparation for local use. It is employed to relieve pain, inflammation and irritation of the mouth and throat in adults and adolescents.

GNH USA supplies Neo-Angin Benzydamin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Neo‑Angin Benzydamin is an NSAID that acts locally on inflamed oromucosal tissues. - Sore throat: reduces pain and swelling, providing symptomatic relief. - Pharyngitis: diminishes inflammatory response and eases discomfort. - Oral mucositis: soothes mucosal irritation and improves comfort during healing. - Mouth ulcer: alleviates ulcer pain and supports faster resolution.

Benzydamine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Mild burning or stinging sensation at the site of application - Altered taste sensation - Transient nausea - Local irritation or erythema

Serious or Rare Side Effects: - Allergic reactions including angioedema - Severe mucosal ulceration or necrosis - Anaphylaxis - Stevens‑Johnson syndrome (rare)

Use Neo‑Angin Benzydamin with awareness of the following safety considerations. - Pregnancy: safety not established; avoid unless benefits outweigh risks. - Breastfeeding: unknown; consider potential exposure to the infant. - Age: not recommended for children under 6 years without medical supervision. - Allergy: discontinue immediately if hypersensitivity signs appear. - Concomitant oral ulcer therapies: monitor for additive irritation. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Benzydamine may interact with other agents that affect the oral mucosa or systemic bleeding risk.

Major Interactions (Avoid): - Concurrent use of other topical anesthetics may increase local numbness. - Combined systemic NSAIDs may raise the risk of gastrointestinal irritation.

Moderate Interactions (Monitor Closely): - Anticoagulants or antiplatelet drugs may augment bleeding tendency. - Alcohol consumption can enhance mucosal irritation. - Use with other oral antiseptics may alter local absorption or irritation profile.